Plasmonic Fluor-Enhanced Antigen Arrays for High-Throughput, Serological Studies of SARS-CoV-2.

Authors:
Qavi AJ; Wu C; Lloyd M; Zaman MM; Luan J and 5 more

Journal:
ACS Infect Dis

Publication Year: 2022

DOI:
10.1021/acsinfecdis.2c00086

PMCID:
PMC9344907

PMID:
35867632

View on PubMed View on PMC View Publisher
Journal Information

Full Title: ACS Infect Dis

Abbreviation: ACS Infect Dis

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Anti-Infective Agents

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Chelation of Mitochondrial Iron as an Antiparasitic Strategy.
Arbon D; Mach J; Čadková A and 10 more (2024) - Transparency Score: 3/6
Enhanced Antimalarial and Antisequestration Activity of Methoxybenzenesulfonate-Modified Biopolymer…
Najer A; Kim J; Saunders C and 3 more (2024) - Transparency Score: 3/6
Extracellular Vesicles in Malaria: Shedding Light on Pathogenic Depths.
Dey S; Mohapatra S; Khokhar M and 2 more (2024) - Transparency Score: 2/6
Heterologous Sarbecovirus Receptor Binding Domains as Scaffolds for SARS-CoV-2 Receptor Binding Mot…
Hauser BM; Sangesland M; Lam EC and 10 more (2024) - Transparency Score: 3/6
High Target Homology Does Not Guarantee Inhibition: Aminothiazoles Emerge as Inhibitors of <i>Plasm…
Johannsen S; Gierse RM; Krüger A and 23 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"The authors declare the following competing financial interest(s): S.L.C., J.L., and M.M.-U.Z. are shareholders of Auragent Bioscience. S.L.C. and M.M.-U.Z. are currently employees of Auragent Bioscience."

Evidence found in paper:

"A.J.Q. was funded by the T32 Cancer Biology Award (NIH CA009547). Research was supported by Fast Grant #2161 (Emergent Ventures) to G.K.A., NIH grants (P01AI120943 and R01AI123926 to G.K.A., R01AI107056 to D.W.L., and R44AI155213 to S.L.C.). S.L.C., J.L., and M.M.Z. are shareholders of Auragent Bioscience. S.L.C. and M.M.Z. are currently employees of Auragent Bioscience."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025